URATE-LOWERING THERAPY WITH VERINURAD AND FEBUXOSTAT REDUCES SERUM URIC ACID AND ALBUMINURIA IN HYPERURICEMIC PATIENTS WITH DIABETES Breadcrumbs UL Home Research Publications Year of Publication 2019 Publisher BMJ PUBLISHING GROUP Journal Annals Of The Rheumatic Diseases DOI 10.1136/annrheumdis-2019-eular.4601